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Abstract
AIM: To describe the cardiovascular disease (CVD) risk 
factors in a population of children with celiac disease 
(CD) on a gluten-free diet (GFD).
METHODS: This cross-sectional multicenter study was 
performed at Schneider Children’s Medical Center of 
Israel (Petach Tiqva, Israel), and San Paolo Hospital 
(Milan, Italy). We enrolled 114 CD children in serologic 
remission, who were on a GFD for at least one year. At 
enrollment, anthropometric measurements, blood lipids 
and glucose were assessed, and compared to values at 
diagnosis. The homeostasis model assessment-estimat-
ed insulin resistance was calculated as a measure of 
insulin resistance. 
RESULTS: Three or more concomitant CVD risk factors 
[body mass index, waist circumference, low density 
lipoprotein (LDL) cholesterol, triglycerides, blood pres-
sure and insulin resistance] were identified in 14% of 
CD subjects on a GFD. The most common CVD risk fac-
tors were high fasting triglycerides (34.8%), elevated 
blood pressure (29.4%), and high concentrations of 
calculated LDL cholesterol (24.1%). On a GFD, four 
children (3.5%) had insulin resistance. Fasting insulin 
and HOMA-IR were significantly higher in the Italian 
cohort compared to the Israeli cohort (P  < 0.001). 
Children on a GFD had an increased prevalence of 
borderline LDL cholesterol (24%) when compared to 
values (10%) at diagnosis (P  = 0.090). Trends towards 
increases in overweight (from 8.8% to 11.5%) and 
obesity (from 5.3% to 8.8%) were seen on a GFD. 
CONCLUSION: This report of insulin resistance and 
CVD risk factors in celiac children highlights the impor-
tance of CVD screening, and the need for dietary coun-
seling targeting CVD prevention. 
© 2013 Baishideng. All rights reserved.
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Core tip: In our study we demonstrate a relatively high 
proportion of children with celiac disease (CD) adherent 
to a gluten-free diet (GFD) with one or more cardio-
vascular disease (CVD) risk factors. Furthermore, this 
is the first report of insulin resistance in celiac patients 
either in adults or children. These findings suggest that 
screening for CVD risk factors in celiac children both at 
diagnosis and during follow-up is important. Further-
more, dietary counseling over time, targeting obesity 
and CVD risk factors in addition to monitoring adher-
ence to a GFD in children and adolescents diagnosed 
with CD, may be warranted.
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INTRODUCTION
Celiac disease (CD) is a common gastrointestinal auto-
immune disorder characterized by inflammation of  the 
small bowel mucosa triggered and sustained by inges-
tion of  gluten in genetically predisposed individuals[1]. 
The prevalence of  CD worldwide ranges between 0.5% 
and 3% of  the general population[2-4]. Although CD has 
traditionally been considered a malabsorptive disorder 
associated with diarrhea and weight loss, these symptoms 
are now seen less frequently[5]. Several recent studies have 
reported that only a minority of  newly diagnosed patients 
were underweight. Instead, many patients, both children 
and adults were overweight or even obese[6,7]. 
A definitive diagnosis of  CD is currently made using 
IgA anti-tissue transglutaminase (tTG) antibody screen-
ing followed, in most cases, by confirmatory biopsies 
of  the small intestine with compatible histopathological 
findings[8]. Currently, the only treatment for CD is a strict, 
life-long gluten-free diet (GFD) which leads to rapid 
clinical improvement, especially in children. The normal-
ization of  serological tests usually occurs 6 to 12 mo after 
initiation of  a GFD[2]. 
Deranged adiposity, blood lipid profile abnormalities 
and other risk factors for cardiovascular disease (CVD) in 
CD patients are still debated, and clear conclusions have 
yet to be reached[9]. Several studies have demonstrated 
that CVD risk factors, namely obesity, abnormal blood 
lipid profile, hypertension and insulin resistance have 
their roots in childhood and tend to track into adult-
hood[10-12]. The primary aim of  this study was to describe 
CVD risk factors in a population of  celiac children ad-
herent to a GFD for at least one year, in two Mediterra-
nean countries.
MATERIALS AND METHODS
This cross-sectional multicenter study was performed at 
Schneider Children’s Medical Center of  Israel (Petach 
Tiqva, Israel), and San Paolo Hospital (Milan, Italy) be-
tween June 2010 and December 2011. 
The study population included individuals less than 18 
years old, previously diagnosed with CD, without known 
co-morbidities, who were referred for follow-up to the 
pediatric gastroenterology clinics of  the participating 
centers. Patients were included if  they had a definitive di-
agnosis of  CD, ascertained by both positive serology and 
confirmed by compatible duodenal biopsies, and who 
had been on a GFD for at least one year with complete 
normalization of  their CD serology (tTG antibodies) at 
the time of  enrollment. 
At enrollment, all patients underwent physical exami-
nation including measurement of  weight using a digital 
scale, and height using a stadiometer. Measurement of  
waist circumference was performed with a tape measured 
to the nearest 0.5 cm at the midpoint between the bot-
tom of  the rib cage and the top of  the iliac crest. Blood 
pressure was measured in the sitting position using an 
appropriately sized cuff. Body mass index (BMI) was 
calculated as weight in kilograms divided by height in me-
ters squared. To evaluate BMI values across different age 
and gender groups we used the BMI standard deviation 
score percentiles that were calculated according to the 
Center of  Disease Control and Prevention growth charts 
of  2000[13]. Children with BMI values lower than the 5th 
percentile for age and gender were classified as “under-
weight”, those in the 5th to 85th percentile were classified 
as “normal weight”, those in the 85th and 95th percentile 
were classified as “overweight” and those greater than the 
95th percentile were classified as “obese”[13]. Pre-hyperten-
sion was defined as an average systolic or diastolic blood 
pressure between the 90th and 95th percentile for sex, age, 
and height-percentile-specific, and hypertension if  the 
values were above the 95th percentile[14]. The same pedia-
trician performed the Tanner stage of  puberty. 
After an overnight fast of  at least 8 h, blood samples 
were drawn for fasting glucose and insulin, triglycerides, 
total cholesterol, high density lipoprotein (HDL) choles-
terol and tTG antibodies. The samples were analyzed in 
local laboratories. tTG antibody levels were quantified by 
enzyme linked immunosorbent assay. Serum glucose level 
was measured by the enzymatic UV test method using 
an automated analyzer and total cholesterol, triglycerides, 
and HDL cholesterol concentrations were measured by 
an enzymatic colorimetric method on an automated ana-
lyzer. LDL cholesterol was calculated using the Fridewald 
equation: LDL cholesterol = total cholesterol - [HDL 
cholesterol + (triglyceride/5)]. Serum insulin concentra-
tions were measured by an immunometric assay with 
the Immulite 2000 Analyzer. According to the American 
Academy of  Pediatrics (AAP) criteria, borderline levels of  
cholesterol were defined by values between the 75th and 
95th percentile of  LDL cholesterol, while values greater 
than the 95th percentile were considered elevated[15]. In-
sulin resistance was estimated by the homeostatic model 
assessment (HOMA-IR), as follows: HOMA-IR = [fast-
ing insulin (μU/mL) × fasting glucose (mmol/L)/22.5). 
Although the hyperinsulinemic euglycemic clamp is the 
only validated method to evaluate insulin sensitivity in 
the pediatric population, HOMA has been widely used 
to estimate insulin resistance in the screening of  large 
populations of  euglycemic children[16]. In this study, in-
sulin resistance was defined as HOMA > 3.16 according 
to the most recent cut-off  for the pediatric population[17]. 
Based on the Bogalosa Heart Study[11], we analyzed six 
risk factors for CVD. The CVD risk factors considered 
were BMI Z-scores greater than the 85th percentile, waist 
circumference over the 90th percentile[18], fasting LDL 
cholesterol or triglycerides higher than the 75th percentile, 
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systolic or diastolic blood pressure greater than the 90th 
percentile and the state of  insulin resistance[19]. 
In addition, we retrieved all the available data on an-
thropometry, blood lipids and glucose profiles at the time 
of  diagnosis of  CD from patient files. 
This study was approved by the institutional review 
boards at each of  the participating centers. Signed in-
formed consent was provided by a legal guardian of  each 
participant.
Statistical analysis
Descriptive data are shown as mean ± SD or number 
of  observations (percentage). Symmetry of  distribution 
of  the variables was tested by the Kolmogorov-Smirnov 
test (P > 0.05). Triglycerides were not symmetrically dis-
tributed and were therefore log-transformed for analysis. 
Comparisons between the groups for continuous vari-
ables were performed by the t test for unpaired data or 
the Wilcoxon-Mann-Whitney test as appropriate. The 
χ2 test for unpaired discrete variables and the Wilcoxon-
Mann-Whitney test for paired discrete variables were 
used in this study. Additionally, a multiple logistic regres-
sion analysis was performed to assess the independent as-
sociation of  the center with HOMA-IR, adjusted for age, 
gender, BMI Z-score, Tanner stage and duration of  diet. 
All P-values less than 0.05 were considered to indicate 
statistical significance (two tailed test). The SPSS soft-
ware, version 18.0 (SPSS Inc, Chicago, IL, United States) 
was used for the statistical analysis.
RESULTS
During the study period, 114 children with a mean age of  
10.4 (± 4.1) years (70 from Israel and 44 from Italy) were 
enrolled. The two populations of  children had compara-
ble demographic data and anthropometry both at diagno-
sis and after at least 1 year of  a GFD (Table 1). The only 
significant difference was a longer follow-up period in the 
Italian children. Complete fasting lipid profiles prior to 
initiation of  the GFD were available for 52/114 children, 
36/70 from Israel and 16/44 from Italy, and insulin lev-
els were not available from CD diagnosis as prior to our 
study the screening of  lipid and glucose profiles was not 
routinely performed in patients with suspected CD.
CVD risk factors
Overall, 14% of  the cohort had 3 or more concomitant 
risk factors (Figure 1). Only 30.7% of  the cohort did not 
have any risk factors (Figure 1). No significant difference 
was seen in the prevalence of  CVD risk factors between 
the two countries in the cohort. The most common 
CVD risk factors were high fasting triglycerides (34.8%), 
elevated blood pressure (29.4%), and high concentrations 
of  calculated LDL cholesterol (24.1%). 
Anthropometry
We did not find any significant difference in the anthro-
pometrics data between the Israeli and Italian CD chil-
dren (Table 1). Anthropometrics in the whole cohort pri-
or to and following the introduction of  a GFD revealed 
significant increases in both height and weight Z-scores 
with an increase in BMI Z-scores which did not reach 
significance (Table 2). When scores were pooled into the 
CDC BMI categories, we found that both the prevalence 
of  overweight and obesity increased from 8.8% and 5.3%, 
respectively, at the time of  diagnosis to 11.4% and 8.8%, 
respectively, after the introduction of  a GFD. This trend 
did not attain statistical significance (P = 0.105). 
Lipid profile
There were no significant differences in the lipid profiles 
between the Israeli and Italian cohorts, except for higher 
levels of  HDL cholesterol in the Italian patients. Accord-
ing to AAP criteria, 63% of  the patients in our cohort 
had normal LDL cholesterol, 30% had borderline and 
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Table 1  Descriptive data of the study populations at diagnosis 
(T0) and recruitment (T1)
Variable Israel Italy P -value
n 70 44
Sex (female) 71.40% 59.10% 0.176
Age at diagnosis (mo)      77.0 ± 43.5    68.7 ± 48.5 0.185
Duration of GFD (mo)      38.9 ± 30.4    69.7 ± 55.6 < 0.00011
Weight Z-score
   T0   -0.405 ± 1.21 -0.931 ± 1.36 0.357
   T1   -0.172 ± 1.25 -0.240 ± 1.19 0.881
Height Z-score
   T0   -0.397 ± 1.14 -0.682 ± 1.40 0.455
   T1   -0.192 ± 1.78 -0.310 ± 1.02 0.227
BMI Z-score 
   T0 -0.103 ± 1.1 -0.369 ± 1.0 0.489
   T1 -0.025 ± 1.2 -0.162 ± 1.2 0.760
1Statistically significant. Values are mean ± SD or number of subjects 
(percentage). BMI: Body mass index; GFD: gluten-free diet. 
22/114 (19.3%)
Figure 1  Risk factors for cardiovascular disease in pediatric patients 
with celiac disease in serological remission on gluten-free diets. White: 
0 risk factor; Black: 1 risk factor; Bule: 2 risk factors; Light gray: 3 risk factors; 
Red: 4 risk factors; Dark gray: 5-6 risk factors. Risk factors sought included 
BMI Z-scores greater than the 85th percentile, waist circumference over the 90th 
percentile[18], fasting low density lipoprotein cholesterol or triglycerides higher 
than the 75th percentile, blood pressure systolic or diastolic greater than the 90th 
percentile and insulin resistance[19]. 
41/114 (36.0%) 35/114 (30.7%)
22/114 (0.9%)
7/114 (6.1%)
8/114 (7%)
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adherence to a GFD. 
The introduction of  a GFD in CD patients increases 
the intestinal absorption of  both macro and micro-nutri-
ents. This leads to improved weight and height in celiac 
children presenting with malabsorption (weight loss, fail-
ure to thrive, poor weight gain)[20]. In our cohort, the ma-
jority of  patients were of  normal weight at the time of  
diagnosis and the percentage of  overweight or obese pa-
tients was higher than those who were underweight. This 
drift in clinical presentation is concordant with previous 
reports[7] and may be attributed to increased awareness 
and early diagnosis. Alternatively, it may be explained by 
the radical change in diet and lifestyle in developed coun-
tries in recent decades, in line with the increasing preva-
lence of  overweight and obesity in the general popula-
tion. The increased prevalence of  overweight and obesity 
after the introduction of  a GFD in this study, although 
not significant (P = 0.10), may suggest the potential of  
a GFD to increase weight even in children presenting as 
normal or overweight at the time of  CD diagnosis. The 
influence of  a GFD on BMI remains unclear both in 
adults and children[9]. In adults, the debate is mainly based 
on two discordant theories. Dickey et al[21] demonstrated 
further weight gain in patients already overweight at the 
time of  CD diagnosis after the introduction of  a GFD, 
while Cheng et al[22] showed a positive effect of  a GFD 
by demonstrating weight gain in previously underweight 
patients and weight loss in those previously overweight. 
Furthermore a recent study[23] recruiting a very large co-
hort of  adult patients found that strict GFD adherence 
could increase the prevalence of  overweight and obesity 
in CD patients. Contrasting studies have also recently ap-
peared in the pediatric literature. Valletta et al[24] reported 
an increase in the fraction of  overweight children follow-
ing the introduction of  a GFD, while Brambilla et al[25] 
demonstrated a beneficial effect of  GFD on BMI in the 
7% had hypercholesterolemia after at least one year of  a 
GFD (Table 2). Although data on the lipid profile before 
CD diagnosis were available only in 50% of  enrolled 
patients, we found significant increases in both total cho-
lesterol and HDL cholesterol in patients on a GFD. The 
categorization of  the LDL cholesterol values highlighted 
an increase in the prevalence of  borderline cholesterol 
levels (from 9.6% to 23.1%), which did not reach statisti-
cal significance (P = 0.090). 
Insulin resistance
The Italian children were found to have both higher fast-
ing insulin and HOMA-IR levels while on a GFD when 
compared to the Israeli cohort (Table 3). Four patients 
(3.5%) were identified with frank insulin resistance, three 
from Italy, and one from Israel (Table 3). Two of  these had 
normal weight and the remaining patients were overweight.
DISCUSSION
This cross-sectional study is the first to describe the pro-
file of  CVD risk factors in a cohort of  children with CD 
in serologic remission on a GFD. Furthermore, this is the 
first report of  insulin resistance in children with CD on a 
GFD. 
Less than one third of  our cohort did not have any 
CVD risk factors, while 14% had three or more risk fac-
tors. This finding suggests that CVD screening may be 
important in pediatric CD patients both at diagnosis and 
during follow-up. Studies have demonstrated that an 
earlier onset and greater number of  CVD risk factors in-
crease the chance of  atheromatous plaque formation[10,11].
Our study design, which did not include a healthy 
control group, did not intend to determine whether chil-
dren with CD have a higher risk than the general popula-
tion for the development of  CVD. Further prospective 
studies are needed to evaluate if  changes in lifestyle and 
environment are responsible for a higher cardiovascular 
risk in celiac patients compared with the normal popula-
tion. Nevertheless, although this study is limited by the 
lack of  data prior to initiation of  a GFD, it may suggest 
that the clinical and dietary follow-up should target adi-
posity, lipid profile and other CVD risk factors in addi-
tion to the common practice of  dietary monitoring of  
Table 2  Changes in height, weight, and body mass index at 
diagnosis (T0) and recruitment (T1)  n  (%)
Variable T0 T1 P -value
Z-score height   -0.447 ± 1.1   -0.238 ± 1.1    0.0011
Z-score weight   -0.567 ± 1.3   -0.198 ± 1.2 < 0.0011
BMI Z-score   -0.207 ± 1.1   -0.078 ± 1.2    0.103
BMI categories2
   Underweight 11/114 (9.6)   12/114 (10.5)
   Normal weight   87/114 (76.3)   79/114 (69.3)
   Overweight 10/114 (8.8)   13/114 (11.4)
   Obese   6/114 (5.3) 10/114 (8.8)    0.105
1Statistically significant; 2Classification[13]. Values are mean ± SD or number 
of subjects (percentage). BMI: Body mass index. 
Table 3  Lipidic, glycemic and insulinemic profile at 
enrollment in the two populations  n  (%)
Variable Israel Italy P -value
Total cholesterol (mg/dL)  158.3 ± 27.6  162.5 ± 24.9   0.570
Cholesterol LDL (mg/dL) 95.4 ± 21    89.9 ± 22.3   0.116
Cholesterol HDL (mg/dL)    49.9 ± 10.6    59.4 ± 12.4 < 0.0011
Triglycerides (mg/dL)    71.1 ± 25.2    62.7 ± 20.9   0.055
LDL cholesterol classes2
   Normal 44/70 (62.9) 28/44 (63.6)
   Borderline 22/70 (31.4) 12/44 (27.3)
   Hypercholesterolemia 4/70 (5.7) 4/44 (9.1)   0.742
Glucose (mg/dL)  83.4 ± 6.9  80.3 ± 8.8      0.0461,3
Insulin μU/mL    3.3 ± 2.7    7.5 ± 4.3   < 0.0011,3
HOMA index  0.69 ± 0.6  1.55 ± 1.0      0.0011,3
Insulin resistance
   HOMA-IR < 3.16 69/70 (98.6) 41/44 (93.2)
   HOMA-IR > 3.16 1/70 (1.4) 3/44 (6.8)   0.108
1Statistically significant; 2AAP classification[15]; 3P-values are adjusted for 
age, gender, body mass index (BMI) Z-score, Tanner stage and duration 
of diet. Values are mean ± SD or number of subjects (percentage). HOMA-
IR: Homeostasis model assessment-estimated insulin resistance; LDL: Low 
density lipoprotein. 
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majority of  CD children. Reilly et al[26] found a beneficial 
effect of  GFD on the BMI of  overweight celiac children. 
Our data, demonstrating that a GFD increases the preva-
lence of  overweight and obesity in children with CD, is 
in agreement with studies reporting increased weight as a 
potential adverse effect of  GFD.
The data concerning LDL cholesterol after at least 
one year of  a GFD suggests an important role for cho-
lesterol as a CVD risk factor in our cohort. In this study, 
LDL cholesterol was the third most prevalent CVD risk 
factor in celiac children on a GFD. 
The increase in total and HDL cholesterol after GFD 
introduction in comparison to levels prior to initiation 
of  a GFD (available from a subset of  patients), is con-
cordant with some studies which theorized that derange-
ment of  intestinal absorption, chylomicron production 
and lipoprotein metabolism may underlie the finding of  
lower levels of  total and HDL cholesterol in untreated 
CD, which can revert to normal after treatment[27-30]. In 
contrast, we found that the rate of  borderline LDL cho-
lesterol concentrations more than doubled (from 9.6% to 
23.1%) following adherence to a GFD. This may be the 
result of  a tendency in adult and adolescent patients to 
consume gluten-free products with high fat contents[31-33] 
in order to compensate for the withdrawal of  common 
gluten-containing carbohydrates from the diet. 
Our data seem to suggest that although the increase 
in the rate of  borderline LDL cholesterol could raise the 
cardiovascular risk, the concomitant increase in HDL 
may be cardioprotective, and thus future studies looking 
at surrogate markers of  atherosclerosis are needed to de-
termine whether a GFD is harmful in this regard. 
Four children (3.5%) on a GFD had insulin resis-
tance. As far as we are aware, the only studies reporting 
HOMA-IR in CD were performed in patients with con-
comitant insulin-dependent diabetes mellitus (IDDM) 
1[34]. It is not known whether insulin resistance was pres-
ent on CD diagnosis. As such, this is the first description 
of  the presence of  insulin resistance in CD children. 
Due to the lack of  insulin levels before CD diagnosis, 
we were unable to assess whether such insulin resistance 
is directly related to the introduction of  a GFD. Previ-
ous publications have reported that available gluten-free 
products (e.g., gluten-free bread, pasta, pizza etc.) have 
much higher glycemic indices than their gluten-contain-
ing equivalents, ingestion of  which may lead to increased 
secretion of  insulin[35-37]. Our findings, along with the 
previously mentioned change in the pattern of  CD pre-
sentation, may suggest that future assessment of  fasting 
glucose and insulin in children diagnosed with CD before 
and during the introduction of  GFD should be per-
formed. This is especially true in light of  the role of  in-
sulin resistance as a CVD risk factor, and a predisposing 
condition for the development of  type 2 diabetes[19]. The 
significantly higher fasting insulin levels and HOMA-IR 
in our Italian cohort may be explained by genetic and di-
etary differences between the two groups[37]. Our findings 
suggest that despite the classical consideration of  CD as 
a malabsorptive condition, metabolic derangements, gen-
erally not attributed to this condition, should be actively 
sought even in patients who are non-obese. Although our 
data may hint to insulin resistance as a new complication 
of  CD, a word of  caution is due, as this study was per-
formed on a cohort of  CD patients and data is lacking in 
the literature regarding the prevalence of  glucose intoler-
ance in the healthy, non-overweight/obese children and 
adolescents.
This study has a number of  limitations such as the 
relatively small number of  patients, the cross-sectional 
design which did not allow for pre-GFD levels of  all 
measured parameters, and the lack of  familial history for 
CVD risk factors which may have further impacted our 
findings. However, despite these limitations, we have de-
scribed the presence of  insulin resistance in pediatric CD 
for the first time, and specifically addressed other CVD 
risk factors in the pediatric CD population on a GFD in 
serological remission. 
Prior to initiation of  the study, the relationship be-
tween CD and CVD risk factors was not clear, and 
therefore screening of  lipid and glucose profiles was not 
routinely performed in patients with suspected CD. Ad-
ditionally, the similarity in most findings between patients 
from two different countries, suggest that these findings 
are neither geographically nor ethnically specific. Pro-
spective studies are needed to delineate the role of  the 
GFD in the development of  CVD risk factors in celiac 
children. 
In conclusion, this cross-sectional study demonstrates 
a relatively high proportion of  children with CD adherent 
to a GFD with one or more CVD risk factors including 
insulin resistance. These findings suggest the importance 
of  screening for CVD risk factors in celiac children both 
at diagnosis and during follow-up. Furthermore, dietary 
counseling over time, targeting obesity and CVD risk 
factors in addition to monitoring adherence to a GFD 
in children and adolescents diagnosed with CD, may be 
warranted.
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